Target intelligence / Profile preview

Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 7 (UBA52P7)

Target
UBA52P7
Molecular classification
Pseudogene, Derived from ubiquitin/ribosomal protein gene family
01

Overview

UBA52P7 (ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 7) is a processed pseudogene in humans that originated from the UBA52 gene, which normally encodes a ubiquitin-ribosomal fusion protein[2][4][6]. Pseudogenes such as UBA52P7 contain sequence defects (such as deletions or mutations) that disrupt their coding capacity, so they do not produce functional protein products[4][5][6]. Pseudogene families corresponding to ubiquitin genes are common in mammals, resulting from gene duplication and retrotransposition events. Most are non-transcribed and have no known functional or disease associations[4][5][6]. UBA52P7 may sometimes be referenced in genetic or genomic databases, but it is not therapeutically relevant. While isolated reports suggest an emerging interest in some ubiquitin pseudogenes for possible regulatory RNA roles or rare cryptic function, there is no current evidence or consensus for such a role for UBA52P7[5][6].

Other names
RPL40_2_1281
02

Mechanism of action

Not applicable for this pseudogene.

03

Biological functions

None for this pseudogene
04

Disease associations

None established
05

Safety considerations

Not applicable
06

Interacting drugs

None
07

Biomarkers

None identified

Beyond the preview

Go deeper on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 7 (UBA52P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 7 (UBA52P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call